Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11357820 GIP/GLP1 agonist compositions

Patent 11357820 was granted and assigned to Eli Lilly and Company on June, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Eli Lilly

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11357820

Date of Patent

June 14, 2022

Patent Application Number

16441329

Date Filed

June 14, 2019

Patent Citations Received

‌

US Patent 11918623 GIP/GLP1 agonist compositions

Patent Primary Examiner

CPC Code

A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11357820 GIP/GLP1 agonist compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API